Skip to content

Screening Cardiovascular Patients for Aortic Aneurysms

Screening Cardiovascular Patients for Aortic Aneurysms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01643317
Acronym
SCAN
Enrollment
35
Registered
2012-07-18
Start date
2012-07-31
Completion date
2013-07-31
Last updated
2019-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Brief summary

Screening studies for Abdominal Aortic Aneurysms (AAA) in 65 to 79 years aged men, have shown a significant reduction in AAA related mortality. In addition, the cost-effectiveness of screening for AAA in men in the Netherlands has been demonstrated by using a Markov model. Screening might be even more (cost-) effective if targeted on high risk groups, such as patients with a particular cardiovascular disease with a known increased risk of having an AAA. Project SCAN (Screening CardioVascular patients for Aortic aNeurysms) is a project focused on targeted AAA screening to proactively diagnose patients at high risk of having an aneurysm that eventually may rupture. This pilot project aims to study the value of a screening protocol in daily practice to detect AAA's in high risk patients.

Detailed description

1. Offering PAD and CAD patients a non-invasive abdominal ultrasound after a careful process of shared-decision making 2. Recording data on aneurysm detection on all PAD and CAD patients screened: 1. General information (age, gender) 2. Medical history on CardioVascular risk factors (such as smoking history, hypertension, and other cardiovascular medical conditions - only information that is already recorded in the patient's medical history chart) 3. AAA - Yes/ No (Yes if ≥3 cm AAA) 4. If ≥3 cm aneurysm, record exact size and outcome in time (surveillance, treatment, no treatment) 5. If treated, record treatment type (EVAR or Open) and outcome

Interventions

None listed

Sponsors

Catharina Ziekenhuis Eindhoven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* male and female patients * peripheral arterial disease (ankle brachial index \< 0,90 and/or reduction of \> 0.15 after exercise test) or a carotid stenosis (stenosis ≥ 50%) * age \> 55 year

Exclusion criteria

* Patients unfit for endovascular or open surgery (as judged by vascular surgeon) * Failure to master the dutch language

Design outcomes

Primary

MeasureTime frame
AAA prevalence1 year

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026